Acne: What’s New and What’s to Come?
I still treat my acne twice daily with a whole cabinet full of various topicals. I’ve tried and failed doxycycline because it disrupts every single molecule of bacterial flora in my body. I’ve tried and failed spironolactone because I was the poster child for nearly all of its annoying and inconvenient side effects. I’ve tried and failed several OCPs because my body was a little too convince …
I still treat my acne twice daily with a whole cabinet full of various topicals. I’ve tried and failed doxycycline because it disrupts every single molecule of bacterial flora in my body. I’ve tried and failed spironolactone because I was the poster child for nearly all of its annoying and inconvenient side effects. I’ve tried and failed several OCPs because my body was a little too convince … 
Each month the JDD Podcast discusses a current issue in dermatology. During the month of September, podcast host Dr. Adam Friedman sat down with Dr. Andrew Alexis, Chair of Dermatology at Mt. Sinai St. Lukes and Mount Sinai West to discuss misconceptions regarding the aesthetic skin of color consumer.
Dr. Angela Hou, PGY-3 dermatology resident at George Washington University School of Medicine … 
Morbihan Disease (MD) is a rare condition but can be a very rewarding diagnosis to make. I interviewed Dr. Kimberly Huerth on her poster presentation of an African-American man with long-standing, progressive Morbihan Disease that took 16 years to diagnose. MD in patients of skin of color may be underreported as well as underdiagnosed. Similarly, rosacea in skin of color is often overlooked and th … 
A full head of hair. This is how I came away from Dr. Heather Woolery-Lloyd’s lecture on hair and scalp disorders at the 2019 Skin of Color Update. There were many aspects of her talk that challenged me to rethink how I approach the management of hair loss in my patients. In this post we will cover biotin’s role in treating alopecia, and important considerations in the treatment of central cen … 
Skin color comes in all shades. Similarly, dermatologists should reflect the diversity that is apparent in our patients. However, in the US, African-Americans make up 12.8% of the population while there are only 3% of Black dermatologists.1 Addressing this gap is beneficial because studies have shown race-concordant visits are longer and have higher levels of patient satisfaction and patient engag … 